Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East

被引:0
|
作者
Anat Achiron
Hany Aref
Jihad Inshasi
Mohamad Harb
Raed Alroughani
Mahendra Bijarnia
Kathryn Cooke
Ozgur Yuksel
机构
[1] Sheba Medical Center,Multiple Sclerosis Center
[2] Ain Shams University,Division of Neurology, Department of Medicine
[3] Rashid Hospital and Dubai Medical College,undefined
[4] Department in Monla Hospital,undefined
[5] Amiri Hospital,undefined
[6] Novartis Healthcare Pvt. Ltd.,undefined
[7] Novartis Pharma AG,undefined
来源
BMC Neurology | / 17卷
关键词
Real-world; Observational; Fingolimod; Other DMTs; Health-related quality of life; Effectiveness; Safety; PERFORMS;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East
    Achiron, Anat
    Aref, Hany
    Inshasi, Jihad
    Harb, Mohamad
    Alroughani, Raed
    Bijarnia, Mahendra
    Cooke, Kathryn
    Yuksel, Ozgur
    BMC NEUROLOGY, 2017, 17
  • [2] Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study
    Ticha, Veronika
    Kodym, Roman
    Pocikova, Zuzana
    Kadlecova, Pavla
    CLINICAL DRUG INVESTIGATION, 2017, 37 (02) : 175 - 186
  • [3] Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study
    Veronika Tichá
    Roman Kodým
    Zuzana Počíková
    Pavla Kadlecová
    Clinical Drug Investigation, 2017, 37 : 175 - 186
  • [4] The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study
    Izquierdo, Guillermo
    Damas, Fatima
    Dolores Paramo, Maria
    Luis Ruiz-Pena, Juan
    Navarro, Guillermo
    PLOS ONE, 2017, 12 (04):
  • [5] Real-world evidence on the safety and effectiveness of fingolimod in patients with multiple sclerosis from Taiwan
    Yang, Chih-Chao
    Ro, Long-Sun
    Tsai, Nai-Wen
    Lin, Chou-Ching
    Huang, Wen-Nan
    Tsai, Ching-Piao
    Lin, Thy-Sheng
    Su, Jen-Jen
    Huang, Chin-Chang
    Lyu, Rong-Kuo
    Chen, Hsin-Hua
    Lee, Wei-Ju
    Chen, Po-Lin
    Yang, Audrey
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (01) : 542 - 550
  • [6] Real-world retrospective study of effectiveness and safety of FINgOlimod in relapsing remitting multiple sclerosis in the Middle East and North Africa (FINOMENA)
    Alroughani, Raed
    AlKawi, Zuhair
    Hassan, Ahmed
    Al Otaibi, Hessa
    Mujtaba, Ahmed
    Al Atat, Rami
    Riachi, Naji
    Akkawi, Nabil
    Koussa, Salam
    Inshasi, Jihad
    Alsaadi, Taoufik
    Ahmed, Samar Farouk
    Al-Aasmi, Abdullah
    Zakaria, Magd
    El Fadally, Haitham
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 203
  • [7] Health-related quality of life of patients with multiple myeloma: A real-world study in China
    Li, Xiaozhe
    Liu, Junru
    Chen, Meilan
    Gu, Jingli
    Huang, Beihui
    Zheng, Dong
    Li, Juan
    CANCER MEDICINE, 2020, 9 (21): : 7896 - 7913
  • [8] Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study
    Krupp, Lauren
    Banwell, Brenda
    Chitnis, Tanuja
    Deiva, Kumaran
    Gaertner, Jutta
    Ghezzi, Angelo
    Huppke, Peter
    Waubant, Emmanuelle
    DeLasHeras, Virginia
    Azmon, Amin
    Karan, Rajesh
    BMJ NEUROLOGY OPEN, 2022, 4 (01)
  • [9] EFFICACY, COSTS AND QUALITY OF LIFE IN THE REAL WORLD SETTING FOR PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH FINGOLIMOD: INTERMEDIATE RESULTS FROM THE VIRGILE STUDY
    Aly, S.
    Digoin-Danzin, A.
    Duteil, E.
    Leiba, G.
    Duco, J.
    Chouette, I
    Allaf, B.
    Kobelt, G.
    VALUE IN HEALTH, 2016, 19 (07) : A430 - A430
  • [10] Real-World Evaluation of Health-Related Quality of Life in Patients With Multiple Myeloma From Germany
    Engelhardt, Monika
    Ihorst, Gabriele
    Singh, Moushmi
    Rieth, Achim
    Saba, Grece
    Pellan, Marine
    Lebioda, Andrea
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (02): : E160 - E175